Jonathan Seltzer, M.D., MBA, MA, FACC
Dr. Seltzer is the founder and President of Applied Clinical Intelligence LLC, (ACI). ACI is devoted to providing highly efficient clinical development services for device, drug, and biotech products. In the wireless field, ACI is noted for its design and execution of Cardionet’s pivotal clinical trial which supported their successful reimbursement strategy.
Dr. Seltzer has participated in all arenas of the healthcare system, from private practice to federally-funded molecular cardiology research. As an early advocate of clinical outcomes analysis, he led two nationwide benchmarking efforts and served as co-chair of the Clinical Evaluative Sciences Council of the University Health Consortium. Prior to founding ACI, he worked as VP of Health Systems Research at Premier Research, spearheading early efforts to integrate Premier Hospital’s cost database into clinical development strategies. In the arena of patient safety, he has chaired national and international Data Monitoring Committees in multiple therapeutic areas. In conjunction with the Office of Human Research Protection, he chaired two federally sponsored meetings focused on human subject protection. Additionally, he and his team at ACI have represented numerous companies at the FDA. He was also recently ask to serve on the steering committee of the FDA-funded Clinical Trial Transformation Initiative.
Dr. Seltzer is board-certified in both cardiology and internal medicine and is a Fellow of the American College of Cardiology. He holds a BA (history) from Haverford College, an MBA (operations) and MA (applied economics) from the University of Michigan, and an MD from the University of Pennsylvania. He serves as an IRB member and holds a certification in Healthcare Research Compliance (CHRC). He holds an appointment as a Clinical Assistant Professor at Jefferson Medical College and Director, Clinical Research at the Main Line Health Heart Center.
Applied Clinical Intelligence
Applied Clinical Intelligence was formed in 2001 by medical and technology specialists in the field of clinical trials. The founders realized that technology, appropriately applied, could be used to provide “business intelligence” to their clients and thereby improve clinical trial performance. As such, ACI was created to improve process efficiency in clinical development.